Does PHENPROCOUMON Cause Hyperparathyroidism secondary? 27 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Hyperparathyroidism secondary have been filed in association with PHENPROCOUMON. This represents 2.0% of all adverse event reports for PHENPROCOUMON.
27
Reports of Hyperparathyroidism secondary with PHENPROCOUMON
2.0%
of all PHENPROCOUMON reports
0
Deaths
26
Hospitalizations
How Dangerous Is Hyperparathyroidism secondary From PHENPROCOUMON?
Of the 27 reports, 26 (96.3%) required hospitalization.
Is Hyperparathyroidism secondary Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PHENPROCOUMON. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does PHENPROCOUMON Cause?
Anaemia (242)
General physical health deterioration (172)
Haematochezia (162)
Dyspnoea (140)
Gastrointestinal haemorrhage (122)
Overdose (109)
Dizziness (108)
Haematoma (108)
Product prescribing error (104)
Fall (92)
What Other Drugs Cause Hyperparathyroidism secondary?
ESOMEPRAZOLE (1,357)
OMEPRAZOLE (1,274)
PANTOPRAZOLE (947)
LANSOPRAZOLE (888)
DEXLANSOPRAZOLE (382)
RABEPRAZOLE (108)
DENOSUMAB (60)
FUROSEMIDE (49)
OMEPRAZOLE\SODIUM BICARBONATE (48)
ESOMEPRAZOLE\NAPROXEN (47)
Which PHENPROCOUMON Alternatives Have Lower Hyperparathyroidism secondary Risk?
PHENPROCOUMON vs PHENTERMINE
PHENPROCOUMON vs PHENTERMINE\TOPIRAMATE
PHENPROCOUMON vs PHENTOLAMINE
PHENPROCOUMON vs PHENYLEPHRINE
PHENPROCOUMON vs PHENYLEPHRINE\PHENYLEPHRINE